Streetbeat News

Products Services

AUUD

Auddia Inc.'s shares surged following the announcement that the USPTO awarded the company U.S. Patent 11,935,520 for its core AI technology used in the faidr app, which offers ad-free AM/FM radio stations to paid subscribers.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:36 pm

LPTV

Loop Media, Inc. (NYSE:LPTV) has entered into a strategic partnership with Adnimation Ltd., a Google Certified Publishing Partner, to enhance its CTV ad revenue and diversify demand sources. The collaboration, leveraging Adnimation's CTV Fusion tool and Google's premium demand, has already generated incremental revenue for both companies. Loop Media aims to boost its ad revenue and fill rates across its CTV network by accessing Google's Programmatic Access Library SDK through this partnership.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:36 pm

XIACF

Xiaomi Corporation's (OTC:XIACF) launch of its first electric vehicle (EV), the SU7, in China has sparked a price war in the EV sector, leading to reduced profit margins for several companies. The SU7's competitive pricing has forced smaller EV manufacturers like Zeekr, Nio, and Aito to cut prices on their vehicles. Xiaomi's aggressive entry into the market has been marked by significant consumer interest, with over 50,000 orders received in less than half an hour.

Portfolio Pulse from Anan Ashraf

April 08, 2024 | 12:35 pm

ALAR

Alarum Technologies Ltd. (ALAR) anticipates a strong Q1 2024 performance with over $8.3M in revenue, a 50% increase from Q1 2023, and a record $3.2M in operating cashflow. Subsidiary NetNut's revenues surged by 140% in the same period. The company highlights growth driven by new products like the Web Unblocker.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:35 pm

CALT

Calliditas Therapeutics announced it will present data on Nefecon at the ISN World Congress of Nephrology. This presentation could impact the perception of Nefecon's efficacy and market potential.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:35 pm

CHRS

Coherus BioSciences, Inc. (NASDAQ:CHRS) presented preclinical data for CHS-1000, a novel anti-ILT4 antibody, at the 2024 AACR Annual Meeting. CHS-1000 shows high affinity for ILT4, reverses its immunosuppressive functions, and activates immune cells, suggesting potential to enhance antitumor responses with immunotherapy. CHS-1000 is the first immuno-oncology product developed by Coherus, with an IND submission planned for Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:34 pm

OPTT

RCAT

Ocean Power Technologies, Inc. (OPTT) has formed a strategic alliance with Red Cat Holdings, Inc. (RCAT) to enhance maritime defense solutions. This collaboration integrates OPT's PowerBuoy and WAM-V platforms with Red Cat's Teal 2 Drones, aiming to revolutionize maritime domain awareness for defense and security missions. The alliance is expected to provide real-time intelligence to counter maritime threats and improve operational safety.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:29 pm

SVRA

Savara Inc. (NASDAQ:SVRA), a clinical stage biopharmaceutical company, announced its participation in the American Thoracic Society 2024 International Conference, where it will present new data on autoimmune Pulmonary Alveolar Proteinosis (aPAP). The company, along with its partner Trillium Health LLC, will showcase two abstracts focusing on the healthcare burden of aPAP and the development of a novel laboratory-based autoantibody blood test for aPAP diagnosis. The presentations aim to increase awareness and understanding of this rare lung disease.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:28 pm

LGND

Ligand Pharmaceuticals announced at the 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference that its Captisol-enabled™ Topiramate Injection can substitute an oral dose on a one-to-one basis.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:27 pm

ANSLY

KMB

Ansell (OTC:ANSLY) has agreed to acquire Kimberly-Clark Corp's (NYSE:KMB) personal protective equipment business for $640 million, aiming to enhance its product portfolio in clean room applications and scientific verticals. The acquisition, expected to complete by September 2024, includes the Kimtech and KleenGuard brands, expanding Ansell's offerings in gloves, protective apparel, chemical protective clothing, and safety eyewear. The deal is subject to antitrust approval and customary closing conditions. KMB shares closed slightly lower following the announcement.

Portfolio Pulse from Shivani Kumaresan

April 08, 2024 | 12:26 pm